Hepcidin is highly expressed in AD patients’ serum (Kweon et al., 2019; Delaby et al., 2025), but in the brain of AD, hepcidin expression is reduced and restricted to nerve cells, blood vessels, and damaged neurons (Raha et al., 2013). Here, HAMP is linked to Alzheimer disease.